Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
64 studies found for:    Open Studies | "Parathyroid Diseases"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Parathyroid Diseases" (64 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Anti-3-[18F]FACBC Imaging of Parathyroid Adenomas
Condition: Parathyroid Disease
Intervention: Drug: FACBC
2 Unknown  Preliminary Study for Identification of Calcium-Binding Proteins in the Serum in Various Metabolic Bone Disorders
Conditions: Osteoporosis;   Osteitis Deformans;   Parathyroid Diseases
Intervention:
3 Recruiting Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Conditions: Neuroendocrine Neoplasms;   Thyroid Neoplasms;   Parathyroid Neoplasms;   Adrenal Neoplasm;   Neuroblastoma
Intervention:
4 Recruiting The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid
Condition: Hyperparathyroidism, Secondary
Intervention: Drug: calcium sensing receptor agonist
5 Unknown  Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
Conditions: DiGeorge Syndrome;   22q11.2 Deletion Syndrome
Intervention:
6 Recruiting Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis
Conditions: Nephrocalcinosis;   Renal Calculi;   Hypercalciuria;   Hyperparathyroidism;   Cystinuria
Intervention: Other: videotape for mapping of renal anatomy and papillary biopsy
7 Unknown  Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate
Condition: Cured Primary Hyperparathyroidism, Concommitant Osteopenia or Osteoporosis
Interventions: Drug: Strontium Ranelate + Ca/Vitamin-D;   Drug: Placebo
8 Not yet recruiting A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Condition: Chronic Kidney Disease, Secondary Hyperparathyroidism
Interventions: Drug: Cinacalcet HCl;   Dietary Supplement: Standard of Care
9 Recruiting Effects of PTH Replacement on Bone in Hypoparathyroidism
Conditions: Hypoparathyroidism;   DiGeorge Syndrome
Interventions: Drug: Parathyroid Hormone 1-34;   Drug: PTH 1-34
10 Recruiting Thymus Transplantation Safety-Efficacy
Conditions: Complete DiGeorge Anomaly;   DiGeorge Syndrome;   DiGeorge Anomaly;   Complete DiGeorge Syndrome
Interventions: Biological: Thymus  Tissue for Transplantation;   Procedure: Blood Draw;   Drug: Rabbit anti-thymocyte globulin;   Drug: Cyclosporine;   Drug: Tacrolimus;   Drug: Methylprednisolone or Prednisolone;   Drug: Basiliximab;   Drug: Mycophenolate mofetil
11 Not yet recruiting A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism
Condition: Hypoparathyroidism
Intervention: Drug: EnteraBio's Oral Parathyroid Hormone (1-34)
12 Not yet recruiting Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy
Conditions: Renal Insufficiency, Chronic;   Renal Osteodystrophy
Interventions: Drug: Yougui granules;   Drug: Zuogui granules;   Drug: Yougui granules placebo;   Drug: Zuogui granules placebo
13 Recruiting Phase 2 Study of KHK7580
Condition: Secondary Hyperparathyroidism
Interventions: Drug: Placebo;   Drug: KHK7580 low dose;   Drug: KHK7580 middle dose;   Drug: KHK7580 high dose;   Drug: KRN1493
14 Recruiting Vitamin D Repletion in Primary Hyperparathyroidism
Conditions: Primary Hyperparathyroidism;   Vitamin D Deficiency
Interventions: Dietary Supplement: 10,000 IU Vitamin D3;   Dietary Supplement: Placebo
15 Recruiting Differentially Expressed Proteins in Sporadic Parathyroid Tumors
Conditions: Primary Hyperparathyroidism;   Hypercalcemia
Intervention:
16 Unknown  Genetics and Psychopathology in the 22q11 Deletion Syndrome
Condition: Chromosome 22q11.2 Deletion Syndrome
Intervention:
17 Not yet recruiting Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.
Condition: 22q11 Deletion Syndrome
Interventions: Dietary Supplement: omega-3 PUFAs;   Other: Standard care;   Dietary Supplement: placebo
18 Recruiting Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism
Conditions: Chronic Kidney Disease;   Hyperparathyroidism, Secondary
Intervention: Drug: Cinacalcet HCl
19 Not yet recruiting One Week Comparison Study of PTH and PTHrP Infusions
Conditions: Osteoporosis;   Hypercalcemia of Malignancy;   Hyperparathyroidism;   Bone Diseases, Endocrine
Interventions: Drug: Parathyroid Hormone-related Protein (1-36);   Drug: parathyroid hormone (1-34);   Drug: PTH (1-34) and PTHrP (1-36)
20 Recruiting Renal Osteodystrophy: A Fresh Approach
Condition: Renal Osteodystrophy
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years